ask="9.11"
ask_size="200"
average_daily_volume="143475"
bid="5.15"
bid_size="100"
book_value="3.42"
change="+0.12"
change_from_200_day_moving_average="-0.09"
change_from_50_day_moving_average="0.31"
change_from_52_week_high="-4.58"
change_From_52_week_low="2.33"
change_in_percent="+1.54%"
close="7.92"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.07"
ebitda="-1.40M"
eps_estimate_current_year="-2.63"
eps_estimate_next_quarter="-0.22"
eps_estimate_next_year="-3.36"
ex_dividend_date="N/A"
float_shares="4868000"
high="8.60"
high_52_weeks="12.50"
last_trade_date="3/8/2017"
last_trade_price="7.92"
last_trade_size="837"
last_trade_time="4:00pm"
low="7.84"
low_52_weeks="5.59"
market_capitalization="96.33M"
moving_average_200_day="8.01"
moving_average_50_day="7.61"
name="Recro Pharma
Inc."
notes="N/A"
one_year_target_price="20.00"
open="8.00"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-1.07%"
percent_change_from_50_day_moving_average="+4.08%"
percent_change_from_52_week_high="-36.64%"
percent_change_from_52_week_low="+41.68%"
previous_close="7.80"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.28"
price_per_sales="1.38"
revenue="68.73M"
shares_outstanding="12163000"
short_ratio="4.88"
stock_exchange="NCM"
symbol="REPH"
volume="426573"
weeks_range_52="5.59 - 12.50"
